TEL: +86 571 56623320 EMAIL: [email protected]
Product Name SMAGP Chinese Name 小细胞跨膜糖化蛋白抗体 Alias hSMAGP; small cell adhesion glycoprotein; SMAGP_HUMAN; small cell transmembrane and glycosylated protein; small transmembrane and glycosylated protein. literatures Specific References (2) | SL5844R has been referenced in 2 publications.[IF=3.391] Hongzao Ni. et al. SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/Akt pathway. Arch Biochem Biophys. 2020 Nov;695:108628 WB ; Human.[IF=2.656] Jia et al. SMAGP a novel biomarker of cervical cancer development and progression. (2018) Onco.Targets.Ther. 11:6925-6935 IHC&IF ;Research Area Tumour immunology Cell adhesion molecule TumourCell biologyMaker Immunogen Species Rabbit Clonality Polyclonal React Species (predicted: Human, ) Applications WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 (Paraffin sections need antigen repair)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.Theoretical molecular weight 11kDa Cellular localization cytoplasmic The cell membrane Form Liquid Concentration 1mg/ml immunogen KLH conjugated synthetic peptide derived from human SMAGP: 24-80/97 <Extracellular> Lsotype IgG Purification affinity purified by Protein A Buffer Solution 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Storage Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. Attention This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. PubMed PubMed Product Detail
Scan Wechat Qrcode